Recommended Approach to the Black Patient With End-Stage Renal Disease and Hepatitis C?
19th Jan 2006, 20:31 GMT
The patient is 55 years old and black with a history of hypertension, diabetes mellitus, end-stage renal disease, and hepatitis C (genotype 1) who is undergoing evaluation for renal transplant. Medscape Gastroenterology Adrian Di Bisceglie
Recommended Approach to the Black Patient With End-Stage Renal Disease and Hepatitis C? related news:
- Oncology Drug Websites Foster Loyalty and Brand Growth — Partnerships/ Joint Ventures News from StratCenter.com
- Peregrine Accelerates Tarvacin HCV Study — Bio-Technology News from StratCenter.com
- Dealing With Disease — RedOrbit News - Health
- Inovio Biomedical to Develop Vaccine for Hepatitis C in Partnership with Tripep AB — Financial News News from StratCenter.com
- Benazepril May Be Helpful for Advanced Renal Insufficiency — Medscape Headlines
- Factors Associated With Medication Nonadherence in Patients With COPD — Medscape Pulmonary Medicine Headlines
- Peregrine Announces Acceleration of Its Tarvacin Anti-Viral Hepatitis C Clinical Program — Bio-Technology News from StratCenter.com
- Kidney and pancreas transplants for diabetics — The Diabetes Blog
- Irish asthmatics fail to manage disease properly, study reveals — The Irish Times' Health Top Stories
- Volume 42, number 4: Hepatitis A Virus Infections in Travelers, 1988-2004 — Clin Infect Dis Latest Issue